Dr. Paul Obeng

Dr. Paul Obeng is a specialist clinical Pharmacist in Paediatric Haematology Oncology at the Komfo Anokye Teaching Hospital. He graduated from the Kwame Nkrumah University of Science and Technology (KNUST) with Pharmacy degree and Master of Public Health. He has completed his Fellowship in Clinical Pharmacy at the West Africa Postgraduate College of Pharmacists (WAPCP) and currently the Head of Pharmacy in Paediatric Haematology Oncology at the Komfo Anokye Teaching Hospital.

He has successfully finished his Doctor of Pharmacy and doubles as the adjunct lecturer at KNUST, WAPCP and Ghana College of Nurses and Midwifes. He has extensive training in clinical trials at the Novartis Institutes of Biomedical Research (NIBR), Cambridge USA and currently the study Pharmacist at the Kumasi Center for Sickle Cell Disease (KCSCD). He has been involved in clinical trials including the Severe Malaria in African Children (SMAC), AQUAMAT and Barekuma Multinutrient trial. He is a member of the Sickle Pan-African Research Consortium (SPARCO) and Skills and Standard Care Working Group.

With his extensive research and knowledge in Hydroxyurea (HU), he has been the focal Pharmacist involved in the design and implementation of HU protocol for the management of patients with SCD in the sickle cell unit. He is a consultant Pharmacist for the Hydroxyurea Working Group established by Novartis/Sandoz. He is an active member of the International Society of Oncology Pharmacy Practitioners (ISOPP) and International Society of Paediatric Oncology (SIOP).